Approval of novel biomarkers: FDA's perspective and major requests.
| Publicado en: | Scandinavian Journal of Clinical & Laboratory Investigation. Supplement Vol. 242; pp. 96 - 103 |
|---|---|
| Autores principales: | , , , |
| Formato: | research Journal Article |
| Publicado: |
Taylor & Francis Ltd
Jul2010 Supplement 242
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105026361&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105026361 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0085591X 8ZPW jtl: Scandinavian Journal of Clinical & Laboratory Investigation. Supplement issn: 0085591X maglogo: Y pubinfo: dt: Jul2010 Supplement 242 vid: 242 pid: 377 pub: Taylor & Francis Ltd place: Philadelphia, Pennsylvania artinfo: ui: 105026361 2010682742 10.3109/00365513.2010.493415 NLM20515286 105026361 ppf: 96 ppct: 7 formats: fmt: @attributes: type: P tig: atl: Approval of novel biomarkers: FDA's perspective and major requests. aug: au: Scherf U Becker R Chan M Hojvat S affil: Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD, USA. Uwe.Scherf@fda.hhs.go sug: subj: Biological Markers Chemistry, Clinical Standards Device Approval Diagnosis, Laboratory Standards United States Food and Drug Administration Biotechnology Equipment and Supplies Biotechnology Standards Human Diagnosis, Laboratory Equipment and Supplies Predictive Value of Tests Prognosis Clinical Trials Methods Clinical Trials Standards Reproducibility of Results Risk Factors United States pubtype: Academic Journal doctype: research Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|